These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33359668)

  • 1. Introduction of a model of skin lesions on rats and testing of dissolving microneedles containing 5-aminolevulinic acid.
    Champeau M; Jary D; Vignion-Dewalle AS; Mordon S; de Lassalle EM; Vignoud S; Mortier L
    Int J Pharm; 2021 Feb; 594():120115. PubMed ID: 33359668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid.
    Champeau M; Jary D; Mortier L; Mordon S; Vignoud S
    Int J Pharm; 2020 Aug; 586():119554. PubMed ID: 32652182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolving microneedles containing aminolevulinic acid improves protoporphyrin IX distribution.
    Requena MB; Permana AD; Vollet-Filho JD; González-Vázquez P; Garcia MR; De Faria CMG; Pratavieira S; Donnelly RF; Bagnato VS
    J Biophotonics; 2021 Jan; 14(1):e202000128. PubMed ID: 32981235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors.
    Jain AK; Lee CH; Gill HS
    J Control Release; 2016 Oct; 239():72-81. PubMed ID: 27543445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema.
    Mikolajewska P; Donnelly RF; Garland MJ; Morrow DI; Singh TR; Iani V; Moan J; Juzeniene A
    Pharm Res; 2010 Oct; 27(10):2213-20. PubMed ID: 20676735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
    Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
    Zhao X; Li X; Zhang P; Du J; Wang Y
    J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
    Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
    J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAL-associated methyl nicotinate for topical PDT improvement.
    Stringasci MD; Ciol H; Romano RA; Buzza HH; Leite IS; Inada NM; Bagnato VS
    J Photochem Photobiol B; 2020 Dec; 213():112071. PubMed ID: 33242779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Anayo L; Magnussen A; Perry A; Wood M; Curnow A
    Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
    Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
    Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dermograph for improvement of PpIX precursor's delivery in photodynamic therapy: Experimental and clinical pilot studies.
    Requena MB; Russignoli PE; Vollet-Filho JD; Salvio AG; Fortunato TC; Pratavieira S; Bagnato VS
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101599. PubMed ID: 31731063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
    Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
    J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
    [No Abstract]   [Full Text] [Related]  

  • 16. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Lesar A; Ferguson J; Moseley H
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
    Pierre MB; Ricci E; Tedesco AC; Bentley MV
    Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.